125 related articles for article (PubMed ID: 1983349)
21. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
22. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
23. Repeated pentagastrin-stimulated gastric acid secretory tests carried out in the evaluation of the pharmacodynamics of a new histamine H2-receptor antagonist, SK&F 93479.
Jönsson KA; Bodemar G; Norlander B; Walan A
Scand J Gastroenterol; 1984 Mar; 19(2):209-15. PubMed ID: 6144180
[TBL] [Abstract][Full Text] [Related]
24. [Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin].
Simon B; Bergdolt H; Dammann HG; Müller P
Arzneimittelforschung; 1992 Feb; 42(2):133-5. PubMed ID: 1610422
[TBL] [Abstract][Full Text] [Related]
25. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
26. The effect of ranitidine and cimetidine on pentagastrin and insulin stimulated gastric secretion.
Sheers R; Roberts N
Scand J Gastroenterol Suppl; 1981 Jun; 69():51-9. PubMed ID: 6119783
[No Abstract] [Full Text] [Related]
27. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
28. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
Hamilton MI; Sercombe J; Pounder RE
Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
[TBL] [Abstract][Full Text] [Related]
29. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
[TBL] [Abstract][Full Text] [Related]
30. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
31. The effects of low doses of ranitidine on intragastric acidity in healthy men.
Wyeth JW; Pounder RE; Sercombe JC; Snell CC
Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
[TBL] [Abstract][Full Text] [Related]
32. Effect of ranitidine on intragastric pH in clinically normal neonatal foals.
Sanchez LC; Lester GD; Merritt AM
J Am Vet Med Assoc; 1998 May; 212(9):1407-12. PubMed ID: 9589127
[TBL] [Abstract][Full Text] [Related]
33. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
34. [Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion].
Del Vecchio-Blanco C; Loguercio C; Caporaso N; de Sio I; Romano M; Focareta R; Taranto D
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):331-6. PubMed ID: 9704131
[No Abstract] [Full Text] [Related]
35. Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration.
Fraser AG; Sawyerr AM; Hudson M; Smith M; Pounder RE
Dig Dis Sci; 1994 Jan; 39(1):91-6. PubMed ID: 8281874
[TBL] [Abstract][Full Text] [Related]
36. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
37. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study.
Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Lim S; Pounder RE
Gastroenterology; 1991 Oct; 101(4):948-53. PubMed ID: 1889719
[TBL] [Abstract][Full Text] [Related]
38. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
Muñoz-Navas M; Honorato J; Reina-Ariño M; Márquez M; Herrero E; Villamayor F; Torres J; Roset PN; Fíllat O; Camps F; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and gastric secretory studies of ranitidine in man.
Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
Mathôt RA; Geus WP
Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
